Patient-Centered Communication of Life Expectancy Estimates in Genitourinary Malignancies

Status unconfirmed · Not applicable

Conditions studied: Prostate Cancer Stage I, Kidney Cancer Stage I, Bladder Cancer Stage II, Prostate Cancer Stage II

In brief

Investigators will conduct a randomized trial to determine if providing patient-specific life expectancy estimates during treatment counseling via a targeted, patient-centered communication approach improves shared decision making and reduces rates of overtreatment of genitourinary malignancies.

Key facts

Study ID

NCT03522155

Run by

Cedars-Sinai Medical Center

People needed

136

Starts

2021-09-01

Expected to finish

2023-09-30

Last updated by the study team

2020-02-06

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Newly diagnosed clinical T1-2 prostate adenocarcinoma with Gleason scores of 7 or less
• Newly diagnosed clinical T1a kidney cancer or renal masses < 4cm
• Newly diagnosed clinical T2 nonmetastatic urothelial carcinoma of the bladder

You may not qualify if…

• Under 18 years of age
• Subjects with difficulty communicating or dementia
• Non-English speakers

Where it is running

• Cedars-Sinai Medical Center — Los Angeles, California, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.